dual GPR40/120 agonists (Advinus)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedual GPR40/120 agonists (Advinus)
Drug Alias Namesmall molecule therapeutics (Advinus Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 4 agonistsFree fatty acid receptor 1 agonists
TargetsFree fatty acid receptor 1Free fatty acid receptor 4
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEurofins Advinus Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEurofins Advinus Ltd
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A